UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of patients with medically unexplained physical symptoms in Dutch general practice

Journal of psychosomatic research, 2017-06, Vol.97, p.169-170

2017

Volltextzugriff (PDF)

Molecular and biochemical characterization of the human trk proto-oncogene

Molecular and Cellular Biology, 1989-01, Vol.9 (1), p.24-33

1989

Volltextzugriff (PDF)

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

British journal of cancer, 1995-11, Vol.72 (5), p.1283-1288

1995

Volltextzugriff (PDF)

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Annals of oncology, 1992-06, Vol.3 (6), p.475-480

1992

Volltextzugriff (PDF)

Human resident peritoneal macrophages: phenotype and biology

British journal of haematology, 1994-12, Vol.88 (4), p.712-722

1994

Volltextzugriff (PDF)

Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study

Journal of clinical oncology, 1991-09, Vol.9 (9), p.1687-1691

1991

Volltextzugriff (PDF)

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma

British journal of cancer, 1994-06, Vol.69 (6), p.1111-1114

1994

Volltextzugriff (PDF)

Transformation of mouse fibroblasts with the oncogenes H‐ras or trk is associated with pronounced changes in drug sensitivity and metabolism

International journal of cancer, 1993-05, Vol.54 (3), p.450-455

1993

Volltextzugriff (PDF)

A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma

European journal of cancer (1990), 1995, Vol.31 (1), p.19-25

1995

Volltextzugriff (PDF)

Frequent Generation of Oncogenes by in vitro Recombination of TRK Protooncogene Sequences

Proceedings of the National Academy of Sciences - PNAS, 1988-05, Vol.85 (9), p.2964-2968

1988

Volltextzugriff (PDF)

Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies

Biochemical journal, 1985-07, Vol.229 (2), p.333-341

1985

Volltextzugriff (PDF)

Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma

European journal of cancer (1990), 1997-08, Vol.33 (9), p.1388-1392

1997

Volltextzugriff (PDF)

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-α-2a in patients with metastatic melanoma: A Federation Nationale des Centres de Lutte contre le Cancer Multicenter, Parallel Study

Cancer, 1999, Vol.85 (5), p.1060-1066

1999

Volltextzugriff (PDF)

Prolonged continuous hepatic artery infusion with interleukin-2 in unresectable liver metastases of colorectal cancer: A phase IA—B study

Annals of oncology, 1996-03, Vol.7 (3), p.317-319

1996

Volltextzugriff (PDF)

A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer

British journal of cancer, 1993-12, Vol.68 (6), p.1186-1189

1993

Volltextzugriff (PDF)

Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients

British journal of cancer, 1993-11, Vol.68 (5), p.1036-1042

1993

Volltextzugriff (PDF)

A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma

European journal of cancer (1990), 1992, Vol.28 (2), p.443-446

1992

Volltextzugriff (PDF)

Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma

British journal of cancer, 1992-05, Vol.65 (5), p.723-726

1992

Volltextzugriff (PDF)

Original article: Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Annals of oncology, 1992-06, Vol.3 (6), p.475-480

1992

Volltextzugriff (PDF)

Intensive regimen of cytokines with interleukin-2 and interferon alfa-2b in selected patients with metastatic renal carcinoma

Journal of immunotherapy (1997), 1995-01, Vol.17 (1), p.62-68

1995

Volltextzugriff (PDF)

Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study

Progress in clinical and biological research, 1994, Vol.385, p.293

1994

Volltextzugriff (PDF)

Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma

European journal of cancer (1990), 1992-01, Vol.28 (6), p.1038-1044

1992

Volltextzugriff (PDF)

Pyruvate kinase isozymes and dedifferentiation of (neuro-)ectodermal tumors

Tumor biology, 1985, Vol.6 (1), p.75-87

1985

Volltextzugriff (PDF)

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study

Cancer, 1999-03, Vol.85 (5), p.1060

1999

Volltextzugriff (PDF)

A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma : clinical data and immunomonitoring

Cancer, 1995-02, Vol.75 (4), p.1038-1044

1995

Volltextzugriff (PDF)

1 – 25 von 338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(262)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(198)
Life Sciences & Biomedicine
(115)
Humans
(82)
Physical Sciences
(71)
Biological And Medical Sciences
(61)
Female
(55)
Physics
(50)
Male
(49)
Exact Sciences And Technology
(45)
Chemistry
(42)
Medical Sciences
(41)
Animals
(36)
Middle Aged
(34)
Technology
(34)
Adult
(33)
Infectious Diseases
(28)
Aged
(27)
Oncology
(26)
Fundamental And Applied Biological Sciences. Psychology
(22)
Applied Sciences
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Management of patients with medically unexplained physical symptoms in Dutch general practice

Molecular and biochemical characterization of the human trk proto-oncogene

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Human resident peritoneal macrophages: phenotype and biology

Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma

Transformation of mouse fibroblasts with the oncogenes H‐ras or trk is associated with pronounced changes in drug sensitivity and metabolism

A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma

Frequent Generation of Oncogenes by in vitro Recombination of TRK Protooncogene Sequences

Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies

Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-α-2a in patients with metastatic melanoma: A Federation Nationale des Centres de Lutte contre le Cancer Multicenter, Parallel Study

Prolonged continuous hepatic artery infusion with interleukin-2 in unresectable liver metastases of colorectal cancer: A phase IA—B study

A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer

Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients

A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma

Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma

Original article: Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Intensive regimen of cytokines with interleukin-2 and interferon alfa-2b in selected patients with metastatic renal carcinoma

Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study

Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma

Pyruvate kinase isozymes and dedifferentiation of (neuro-)ectodermal tumors

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study

A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma : clinical data and immunomonitoring

Suchergebnisse filtern